Hepatitis B in the middle east: Aspects of epidemiology and liver disease after infection

Gut

Volumn 38, Issue SUPPL. 2, 1996, Pages

  Toukan, A U ^a,b  

^a UNIVERSITY OF JORDAN   (Jordan)

^b JORDAN UNIVERSITY HOSPITAL   (Jordan)

Author keywords

epidemiology; hepatitis B; Middle East

Indexed keywords

CHRONIC LIVER DISEASE; CONFERENCE PAPER; HEPATITIS B; HUMAN; IMMUNIZATION; INFECTION PREVENTION; MIDDLE EAST; PRIORITY JOURNAL; VIRUS TRANSMISSION;

EID: 0029902755     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.Suppl_2.S2     Document Type: Conference Paper

References (18)

1. Skinhøj P, Al-Kassab S. Hepatitis B antigen in Iraq. Lancet 1973; ii: 1269.
2. Al-Faleh FZ. Hepatitis B infection in Saudi Arabia. Ann Saudi Med 1988; 8: 474-80.
3. Toukan AU, Sharaiha ZK, Abu-El-Rub OA, et al. The epidemiology of hepatitis B virus among family members in the Middle East. Am J Epidemiol 1990; 132: 220-32.
4. El-Guneid AM, Gunaid AA, O'Neill AM, Zureikat NI, Coleman JC, Murray-Lyon IM. Prevalence of hepatitis B, C, and D virus markers in Yemeni patients with chronic liver disease. J Med Virol 1093; 40: 330-3.
5. Alkanderi S, Al-Nakib W. Prevalence of HBsAg and anti-HBs in Kuwait. J Kuwait Med Assoc 1983; 17: 99-105.
6. Nashef L, Thalgi A. Hepatitis B serology among the Palestinian population. Ann Trop Paediatr 1992; 12: 321-5.
7. Bar-Shany S, Green MS, Slepon R, Gilon E. Ethnic differences in the prevalence of hepatitis B surface antigen among Israeli blood donors: changes between 1972 and 1988. Int J Epidemiol 1991; 20: 271-5.
8. Toukan A, and the Middle East Regional Study Group. Strategy for the control of hepatitis B virus infection in the Middle East and North Africa. Vaccine 1990; 8: S117-21.
9. Al-Faleh FZ, Ayoola EA, Arif M. Seroepidemiology of hepatitis B virus infection in Saudi Arabian children: a baseline survey for mass vaccination against hepatitis B. J Infect 1992; 24: 197-206.
10. Toukan A. Hepatitis B virus infection in urban residents of Jordan with particular reference to socioeconomic factors. Trop Gastroenterol 1987; 8: 161-6.
11. Szmuness W, Prince AM, Hirsch RL, Brotman B. Familial clustering of hepatitis B infection. N Engl J Med 1973; 289: 1162-6.
12. McMahon BJ, Alward WLM, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985; 151: 599-603.
13. Beasley RP, Hwang LY, Lin CC, et al. Hepatocellular carcinoma and HBV: a prospective study of 22 707 men in Taiwan. Lancet 1981; ii: 1129-33.
14. Ohbayashi A, Okochi K, Mayumi M. Familial clustering of asymptomatic carriers of Australia antigen and patients with chronic liver disease or primary liver cancer. Gastroenterology 1972; 62: 618-25.
15. Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: epidemiologic considerations. Hepatology 1982; 2: 21-6S.
16. Thursz MR, Kwiatkowski K, Allsopp CEM, Greenwood BM, Thomas HC, Hill AVS. Association between an MHC Class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 1995; 332: 1065-9.
17. Brunetto MR, Stemmlar M, Schodel F, et al. Identification of HBV variants which cannot produce procure derived HBcAg and may be responsible for severe hepatitis. Ital J Gastroenterology 1989; 21: 151-4.
18. Carman WF, Jacyna MR, Hadziyannis S, et al. Mutation preventing formation of e antigen in patients with chronic HBV infection. Lancet 1989; ii: 588-91.